Ibrahim Büdeyri

6PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methodsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 25, 2026
The Prognostic Value of Circulating Stem Cells Expressing PD-L1 in Patients with Hepatocellular Carcinoma.

|Jul 29, 2025
Pelvic Exenteration: An Ultimate Option in Advanced Gynecological Malignancies-A Single Center Experience.

Helmut Plett, Jan Philipp Ramspott, Ibrahim Büdeyri

|Feb 26, 2025
Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Postoperative and Oncologic Outcomes Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Pauline Aeschbacher, Anna Silvia Wenning, Shadi Katou

|Jan 10, 2025
Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma.

Ibrahim Büdeyri, Olaf Guckelberger, Elsie Oppermann

|Oct 26, 2024
Caseload per Year in Robotic-Assisted Minimally Invasive Esophagectomy: A Narrative Review.

Ibrahim Büdeyri, Nader El-Sourani, Ann-Kathrin Eichelmann

|Jun 18, 2020
Pseudopterosin and O-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma.

Bailu Xie, Jan Hänsel, Vanessa Mundorf

Pageof 1

Frequent Collaborators

2 joint publications

Mazen Juratli

2 joint publications

Felix Becker

2 joint publications

Benjamin Struecker

2 joint publications

Thomas J Vogl